Overexpression of CIP2A in bone marrow cells from a group of patients with a high-risk of myelodysplastic syndromes (MDS) has been reported by Li et al., who demonstrated that CIP2A plays an important role in the progression of myelodysplastic syndromes [78]. This evidence concerns the gene CIP2A and myelodysplastic syndrome.